Skip to main content
Log in

Forecasting of Blood Tacrolimus Concentrations Based on the Bayesian Method in Adult Patients Receiving Living-Donor Liver Transplantation

  • Original Research Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Abstract

Objective: To evaluate Bayesian prediction of blood tacrolimus concentrations in adult patients receiving living-donor liver transplantation (LDLT) using previously obtained population pharmacokinetic parameters.

Patients and methods: Data were retrospectively collected from 47 adult patients receiving LDLT who were not included in the estimation of population pharmacokinetic parameters. Blood tacrolimus concentrations were predicted without or with the empirical Bayesian method using sparse samples obtained in the previous week. Predictive performance of the concentrations was evaluated by the mean prediction error (ME), mean absolute prediction error (MAE) and root mean square error (RMSE) as well as the percentage of successful predictions (percentage of absolute prediction error less than 3 μg/L, %PRED3).

Results: Concentrations predicted by the population mean pharmacokinetic parameter values coincided well with observed concentrations during the period of tacrolimus infusion immediately after the operation. For concentrations during subsequent oral therapy with tacrolimus, predictability by the population mean pharmacokinetic parameter values alone was not satisfactory. Bayesian forecasting using one or two blood concentrations obtained in the previous week significantly decreased (p < 0.05) MAE and RMSE compared with predictions based on the population mean pharmacokinetic parameters on postoperative days 21 and 28, but not on day 14. During postoperative days 15–21, %PRED3 was increased to 68.6% or 71.2% with the Bayesian method using one or two blood concentrations, respectively, from 44.9% with the population mean pharmacokinetic parameter values.

Conclusion: The present study demonstrated the applicability of the Bayesian method with use of one or two samples for prediction of blood tacrolimus concentrations in adult patients receiving LDLT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Table III
Table IV
Table V
Fig. 7

Similar content being viewed by others

References

  1. Busuttil RW, Holt CD. Tacrolimus is superior to cyclosporine in liver transplantation. Transplant Proc 1998; 30: 2174–8

    Article  CAS  PubMed  Google Scholar 

  2. Broelsch CE, Whitington PF, Emond JC, et al. Liver transplantation in children from living related donors: surgical techniques and results. Ann Surg 1991; 214: 428–37

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. De Ville De Goyet J, Hausleithner V, Reding R, et al. Impact of innovative techniques on the waiting list and results in pediatrie liver transplantation. Transplantation 1993; 56: 1130–6

    Article  PubMed  Google Scholar 

  4. Tanaka K, Uemoto S, Tokunaga Y, et al. Living related liver transplantation in children. Am J Surg 1994; 168: 41–8

    Article  CAS  PubMed  Google Scholar 

  5. Inomata Y, Tanaka K, Egawa H, et al. The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. Transplantation 1996; 61: 247–52

    Article  CAS  PubMed  Google Scholar 

  6. Yasuhara M, Hashida T, Toraguchi M, et al. Pharmacokinetics and pharmacodynamics of FK 506 in pediatrie patients receiving living-related donor liver transplantations. Transplant Proc 1995; 27: 1108–10

    CAS  PubMed  Google Scholar 

  7. Venkataramanan R, Swaminathan A, Prasad T, et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet 1995; 29: 404–30

    Article  CAS  PubMed  Google Scholar 

  8. Wallemacq PE, Verbeeck RK. Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients. Clin Pharmacokinet 2001; 40: 283–95

    Article  CAS  PubMed  Google Scholar 

  9. Sam WJ, Aw M, Quak SH, et al. Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients. Br J Clin Pharmacol 2000; 50: 531–41

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. García Sánchez MJ, Manzanares C, Santos-Buelga D, et al. Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy. Clin Pharmacokinet 2001; 40: 63–71

    Article  PubMed  Google Scholar 

  11. Staatz CE, Taylor PJ, Lynch SV, et al. Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants. Transplantation 2001; 72: 1056–61

    Article  CAS  PubMed  Google Scholar 

  12. Jusko WJ, Piekoszewski W, Klintmalm GB, et al. Pharmacokinetics of tacrolimus in liver transplant patients. Clin Pharmacol Ther 1995; 57: 281–90

    Article  CAS  PubMed  Google Scholar 

  13. Beal SL, Boeckmann AJ, Sheiner LB. NONMEM Users Guides. San Francisco: NONMEM Project Group, University of California, 1992

    Google Scholar 

  14. Fukatsu S, Yano I, Igarashi T, et al. Population pharmacokinetics of tacrolimus in adult recipients receiving livingdonor liver transplantation. Eur J Clin Pharmacol 2001; 57: 479–84

    Article  CAS  PubMed  Google Scholar 

  15. Sheiner LB, Beal SL, Rosenberg B, et al. Forecasting individual pharmacokinetics. Clin Pharmacol Ther 1979; 26: 294–305

    Article  CAS  PubMed  Google Scholar 

  16. Sheiner LB, Beal SL. Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods. J Pharm Sci 1982; 71: 1344–8

    Article  CAS  PubMed  Google Scholar 

  17. Yukawa E, Higuchi S, Aoyama T. One-point feedback control method for phenytoin dosage adjustment. J Pharm Pharmacol 1991; 43: 499–503

    Article  CAS  PubMed  Google Scholar 

  18. Rodvold KA, Gentry CA, Plank GS, et al. Bayesian forecasting of serum vancomycin concentrations in neonates and infants. Ther Drug Monit 1995; 17: 239–46

    Article  CAS  PubMed  Google Scholar 

  19. Wrishko RE, Levine M, Khoo D, et al. Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients. Ther Drug Monit 2000; 22: 522–31

    Article  CAS  PubMed  Google Scholar 

  20. Charpiat B, Falconi I, Bréant V, et al. A population pharmacokinetic model of cyclosporine in the early postoperative phase in patients with liver transplants, and its predictive performance with Bayesian fitting. Ther Drug Monit 1998; 20: 158–64

    Article  CAS  PubMed  Google Scholar 

  21. Leger F, Debord J, Meur YL, et al. Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants. Clin Pharmacokinet 2002; 41: 71–80

    Article  CAS  PubMed  Google Scholar 

  22. Macchi-Andanson M, Charpiat B, Jelliffe RW, et al. Failure of traditional trough levels to predict tacrolimus concentrations. Ther Drug Monit 2001; 23: 129–33

    Article  CAS  PubMed  Google Scholar 

  23. Grenier FC, Luczkiw J, Bergmann M, et al. A whole blood FK506 assay for the IMx® analyzer. Transplant Proc 1991; 23: 2748–9

    CAS  PubMed  Google Scholar 

  24. Cogill JL, Taylor PJ, Westley IS, et al. Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients. Clin Chem 1998; 44: 1942–6

    CAS  PubMed  Google Scholar 

  25. Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 1981; 9: 503–12

    Article  CAS  PubMed  Google Scholar 

  26. Venkatakrishnan K, von Moltke LL, Greenblatt DJ. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance. Clin Pharmacokinet 2000; 38: 111–80

    Article  CAS  PubMed  Google Scholar 

  27. Floren LC, Bekersky I, Benet LZ, et al. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin Pharmacol Ther 1997; 62: 41–9

    Article  CAS  PubMed  Google Scholar 

  28. Mathis AS, Direnzo T, Friedman GS, et al. Sex and ethnicity may chiefly influence the interaction of fluconazole with calcineurin inhibitors. Transplantation 2001; 71: 1069–75

    Article  CAS  PubMed  Google Scholar 

  29. Jones TE, Morris RG. Pharmacokinetic interaction between tacrolimus and diltiazem: dose-response relationship in kidney and liver transplant recipients. Clin Pharmacokinet 2002; 41: 381–8

    Article  CAS  PubMed  Google Scholar 

  30. Fitzsimmons WE, Bekersky I, Dressier D, et al. Demographic considerations in tacrolimus pharmacokinetics. Transplant Proc 1998; 30: 1359–64

    Article  CAS  PubMed  Google Scholar 

  31. Mancinelli LM, Frassetto L, Floren LC, et al. The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups. Clin Pharmacol Ther 2001; 69: 24–31

    Article  CAS  PubMed  Google Scholar 

  32. Lown KS, Mayo RR, Leichtman AB, et al. Role of intestinal P-glycoprotein (mdr1) in interpatient variability in the oral bioavailability of cyclosporine. Clin Pharmacol Ther 1997; 62: 248–60

    Article  CAS  PubMed  Google Scholar 

  33. Zhang Y, Benet LZ. The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein. Clin Pharmacokinet 2001; 40(3): 159–68

    Article  CAS  PubMed  Google Scholar 

  34. Hashida T, Masuda S, Uemoto S, et al. Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation. Clin Pharmacol Ther 2001; 69: 308–16

    Article  CAS  PubMed  Google Scholar 

  35. Ds’Argenio DZ. Optimal sampling times for pharmacokinetic experiments. J Pharmacokinet Biopharm 1981; 9: 739–56

    Article  Google Scholar 

Download references

Acknowledgements

This project was supported in part by a Grant-in-Aid from Japan Health Sciences Foundation, by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a grant from the Nakatomi Foundation. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ken-ichi Inui.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fukudo, M., Yano, I., Fukatsu, S. et al. Forecasting of Blood Tacrolimus Concentrations Based on the Bayesian Method in Adult Patients Receiving Living-Donor Liver Transplantation. Clin Pharmacokinet 42, 1161–1178 (2003). https://doi.org/10.2165/00003088-200342130-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-200342130-00006

Keywords

Navigation